Paradigm Therapeutics’ SD-101 Nominated for the 2026 Prix Galien USA Award #USA #Mount_Pleasant #Paradigm_Therapeutics #SD-101 #Zorblesia

Paradigm Therapeutics Nominated for Prestigious Prix Galien USA 2026 Award for Innovative Therapy #Paradigm_Therapeutics #SD-101 #Zorblesia

Paradigm Therapeutics, Inc. Nominated for Prix Galien USA 2026 Best Start-Up Award #USA #Epidermolysis_Bullosa #Paradigm_Therapeutics #SD-101 #Mount_Pleasant,_S.C.

Paradigm Therapeutics: 2026 Prix Galien USA Best Start-Up Nominee for Revolutionary EB Treatment #USA #Mount_Pleasant #Epidermolysis_Bullosa #Paradigm_Therapeutics #Zorblesia™

Paradigm Therapeutics Recognized Again for Innovative Therapy in Epidermolysis Bullosa Treatment #Mount_Pleasant #Paradigm_Therapeutics #SD-101 #Zorblesia